Alabama Administrative Code › Title 420 - ALABAMA STATE BOARD OF HEALTH › Chapter 420-7-3 - ALABAMA STATEWIDE CANCER REGISTRY › Section 420-7-3-.01 - General Provisions

Current through Register Vol. 42, No. 9, June 28, 2024
(1) These
			 rules apply to the reporting of cancer or benign brain-related tumors to the
			 Alabama Statewide Cancer Registry.
(2) Statutory Authority. These rules are promulgated and
				  adopted pursuant to the authority of Act 04-396.
(3) Definitions (a list of selected terms often used in
				  connection with these Rules):
(a) "Accuracy" means the correctness of data reported on
				  cancer or benign brain-related tumor cases submitted to the ASCR according to
				  established national standards.
(b) "Advisory Council" means the council appointed by the
				  State Health Officer consisting of healthcare professionals, university
				  representatives, and other interested parties from various health
				  associations.
(c) "ASCR" means the Alabama Statewide Cancer
				  Registry.
(d) "Behavior Code" means a one-digit code which indicates
				  whether a tumor is malignant, benign, in situ, or of uncertain behavior.
(e) "Cancer Registry" means a collection of cancer or benign
				  brain-related tumor data on patients that is maintained as an identified
				  repository of such data for, or within any hospital, medical clinic, or
				  centralized institution.
(f) "Cancer Registrar" means any person appropriately trained
				  for the collection of cancer or benign brain-related tumor data for a cancer
				  registry.
(g) "Cancer Patient" means any person who is undergoing
				  diagnosis or treatment for cancer or benign brain-related tumor.
(h) "Clinical Records" means any records, hard copy or
				  patient abstract, containing information which could lead to the identification
				  of cancer patients, cancer diagnosis or treatment facilities, independent
				  clinical laboratories, or health care providers.
(i) "Clinical Information" means any information which could
				  lead to the identification of cancer or benign brain-related tumor patients,
				  cancer or benign brain-related tumor diagnosis or treatment facilities,
				  independent clinical laboratories, or health care providers.
(j) "Completeness" means the complete reporting of all
				  confirmed cases of cancer or benign brain-related tumor.
(k) "Data Acquisition Manual" means the manual developed by
				  the ASCR which specifies the rules and guidelines used when abstracting a
				  confirmed cancer or benign brain-related tumor case to be reported.
(l) "Death Match" means the matching of confirmed cases of
				  cancer or benign brain-related tumor reported to the central registry with a
				  listing of deceased individuals.
(m) "Direct Reporting" means the reporting of all cancers or
				  benign brain-related tumors from the facility or provider to the central
				  registry via paper or electronic submission.
(n) "Electronic data submission" means transferring data from
				  a computer used by a reporting entity to a computer specified by the ASCR
				  through the use of a modem, magnetic tape, magnetic disk, or secure Internet
				  connection.
(o) "Healthcare Facilities" means all public, private,
				  federal, or military hospitals, surgical centers, outpatient radiation therapy
				  centers, outpatient medical oncology centers, or any other facilities where
				  cancer or benign brain-related tumor cases are diagnosed or treated.
(p) "Healthcare Providers" means a person who is licensed by
				  the Alabama Board of Medical Examiners to practice medicine or the Alabama
				  Board of Dental Examiners to practice dentistry.
(q) "Indirect Reporting" means reporting of all cancers or
				  benign brain-related tumors to the central registry via paper or electronic
				  submission by a facility through contract with an outside facility or
				  registrar.
(r) "Primary Cancer" means any confirmed cancer or benign
				  brain-related tumor not determined to be a metastasis from another primary
				  site.
(s) "Primary Site" means the site of origin of a confirmed
				  cancer or benign brain-related tumor.
(t) "Researcher" means the primary investigator,
				  co-investigator, or project director of a research project or proposal.
(u) "Research Review Committee" means the committee appointed
				  by the State Health Officer consisting of representatives from the ASCR
				  Advisory Council and the ADPH.
(v) "Statistical Data" means collected aggregate data which
				  does not lead to the identification of cancer or benign brain-related tumor
				  patients, cancer or benign brain-related tumor diagnosis or treatment
				  facilities, independent clinical laboratories, or health care providers.
(w) "Timeliness" means the reporting of all confirmed cases
				  of cancer or benign brain-related tumor within 180 days of admission or
				  diagnosis.
Author:
Reda Wilson
Statutory Authority:
Code of Ala.
				  1975
, §
										22-13-1.